ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
87.495
-0.21%
Bitcoin
62,703.45
-0.63%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Bivictrix Therapeutics Plc (BVX) Quote

Bivictrix Therapeutics Plc

Bivictrix Therapeutics Plc (BVX)

LSE
11.50
0.00
(0.00%)
Closed April 28 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
11.50
Bid
11.00
Ask
12.00
Volume
0.00
11.50 Day's Range 11.50
10.45 52 Week Range 15.90
Market Cap
9.491M
Previous Close
11.50
Open
11.50
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
30,847
Shares Outstanding
82,526,088
Dividend Yield
-
PE Ratio
-3.80
Earnings Per Share (EPS)
-0.03
Revenue
-
Net Profit
-2.5M

About Bivictrix Therapeutics Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.bivictrix.com
Headquarters
Manchester, Gbr
Founded
1970
Bivictrix Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker BVX. The last closing price for Bivictrix Therapeutics was 11.50p. Over the last year, Bivictrix Therapeutics shares have traded in a share price range of 10.45p to 15.90p.

Bivictrix Therapeutics currently has 82,526,088 shares outstanding. The market capitalization of Bivictrix Therapeutics is £9.49 million. Bivictrix Therapeutics has a price to earnings ratio (PE ratio) of -3.80.

BVX Latest News

More News

Bivictrix granted FDA orphan drug status for rare cancer treatment

Bivictrix Therapeutics PLC on Wednesday said its BVX001 drug has been granted special status by the US Food and Drug ...

April 17 2024
Alliance News

BiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT Meeting

BiVictriX Therapeutics PLC 17 April 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

April 17 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Grant of Options – PDMR/Director Dealings

BiVictriX Therapeutics PLC 28 March 2024     THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF...

March 28 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 04 January 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK Issuer...

January 04 2024
UK Regulatory

BiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable Discussion

BiVictriX Therapeutics PLC 04 January 2024 BIVICTRIX THERAPEUTICS PLC ("BiVictriX" or the "Company") BiVictriX Hosts Inaugural Roundtable Discussion with Globally Renowned...

January 04 2024
UK Regulatory

BiVictriX Therapeutics PLC Board Change

BiVictriX Therapeutics PLC 05 December 2023 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

December 05 2023
UK Regulatory

IN BRIEF: Bivictrix selects final sequences for lead tumour programme

utics PLC - Macclesfield, England-based biotechnology company focused on cancer therapies - Says final sequences have ...

November 30 2023
Alliance News

BiVictriX Therapeutics PLC Pipeline update on BVX002

BiVictriX Therapeutics PLC 30 November 2023 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH...

November 30 2023
UK Regulatory

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 22 November 2023 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK Issuer...

November 22 2023
UK Regulatory

TRADING UPDATES: BiVictriX patent boost; 4Global deal extended

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

November 15 2023
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10011.511.511.542811.5DE
40.252.2222222222211.2511.510.456359911.36746845DE
120011.511.810.453084711.44069328DE
26-1.5-11.5384615385131310.457903310.8460925DE
52-3.5-23.33333333331515.910.454433711.54537956DE
156-11-48.888888888922.533.510.459715121.17894047DE
260-11-48.888888888922.533.510.459715121.17894047DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
Benwahsauce Benwahsauce 3 minutes ago
Ty sir and appreciate the compliment!

I truly do this to help others and help educate. Inspite of most of IHUB…there are some very talented traders on this platform.

Some… are on completely different level
AMPUSD
Viking61 Viking61 4 minutes ago
New CNN poll, voters polled Trump 49% Biden 43%. This should bode well for us shareholders!! Whether you like Trump or not. GLTA!!
FNMA
arizona1 arizona1 4 minutes ago
Perhaps if she'd been around 20 years earlier, she could have castrated the goat, and he wouldn't have had to die.

Even I know that's what you need to do with an aggressive goat.
lakers17 lakers17 4 minutes ago
George Sharp has done squat. At this point he's a scammer. Has proved nothing. Still holding freebies here but almost worthless. He has lost all credibility.
GVSI
Inquirig Inquirig 4 minutes ago
Cool...
I'm in awe of your ability to be smarter and 5 steps ahead of all the smartest investors in the world who are stuck in the shabby world of buying Nasdaq and NYSE companies with promise, assets, more than 22 employees, institutional backing and marketable products - with competent CEOs
NWBO
LovePennyStock LovePennyStock 5 minutes ago
IMHO, the merger news(in 8-Ks) and filings(10-Qs, 10-Ks)should come all together. It doesn't make sense if you only release merger news or financing package news, but no filings you still in expert market and most of our share holders still can't trade. Or if they only file the past due 10-Qs, 10-Ks
PSPW
just Scottie just Scottie 6 minutes ago
Also think it’s gonna require more patience than A lot of otc pink traders have
FBEC
janice shell janice shell 6 minutes ago
Quiche is okay. One of those things with eggs that I WILL eat. I should think about it. Maybe.
archilles archilles 7 minutes ago
Charles was with BGEN which was sold off to SAGA. Since Charles took the IPs from BGEN and found another bio company under his name, SAGA figured that BGEN was no longer valueable for them and SAGA decided to return BGEN.
We probably won’t be hearing from SAGA or ENZC on this question for an
ENZC
just Scottie just Scottie 7 minutes ago
Yes me too!
FBEC
Box Money Box Money 8 minutes ago
Really?… after all this.. read something .. smh
LEAS
StayHumble StayHumble 8 minutes ago
$DBMM litigated w/Asher🔥4theProtection0fShareholders+Mrkt🔥
Asher Enterprises, Inc. has been sanctioned numerous times by the Commission for Securities §5 violations and, under information and belief, intends to commit further Securities Act §5 violations in DBMM's securitie
DBMM GTII
IronMan123 IronMan123 9 minutes ago
So, dosen't the Lambreth case do exactly that? We just need it finialized, right?
FNMA
Whalatane Whalatane 10 minutes ago
North.With respect . You should know the answer to your question by now ( will a 227 patient Greek trial suffice ?)
Maybe poster Laurent will be willing to spend some time explaining to you the importance of.... size of clinical trials , powering of clinical trials and P values .
AMRN
AlwaysOptimistic AlwaysOptimistic 10 minutes ago
I still think they will get financed. Had I known, however, it would take 11 years, I would still have invested but not as much. That is certain. What’s done is done. Can’t re write history. Kudos to new investors who likely won’t have to endure a tortuous wait. Waiting on EXIM with all the known r
NB
newmedman newmedman 10 minutes ago
lol something in my younger days about quiche eaters, something, something.

Honestly I might like it if I tried it, I just never have.
StayHumble StayHumble 11 minutes ago
Commision🔥Drops$DBMMcase dueto Data Leak Mistake🔥 $DBMM! Digital Brand Media & Marketing Group, Inc.
Intellicell Biosciences, Inc. 3-17990
https://www.sec.gov/litigation/opinions/2023/33-11198.pdf
Minimum 4 Fraud Cases!
"Not Kramer but a Fraud Asscociate"
DBMM DBMMCASE
StayHumble StayHumble 12 minutes ago
FundersWait🔥toEnsure $DBMM Isn'tRevokedby🔥Commission

The Company has the present ability to move forward to continue to grow its business for the benefit of its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its reg
DBMM GTII HPIL
ncstrongman ncstrongman 13 minutes ago
Exactly. Outta trips this week. No doubts
CBIA
arizona1 arizona1 14 minutes ago
He sounds like someone who would also kill a family pet.

'Who kills a puppy?' CNN panel blasts Kristi Noem's murderous streak

CNN contributors blasted South Dakota Gov. Kristi Noem (R), who reportedly shot a 14-month-old puppy to death.

"This is somethin
casper6 casper6 15 minutes ago
"you just can't make this up!!" But that is all you ever do in your usual sick and convoluted way as usual. Watchdogs? Try watchbulldogs.. hard to shake them off ehh farty?
As hard as you have tried.. isn't happening is it? Still all fun and games?
Can't stand it can you?
EGOC

Your Recent History

LSE
BVX
Bivictrix Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved